Therapeutic Action
Antispasmodic, anticholinergic drug
PDF page 420
Loading InternPractice…
Drug reference
Antispasmodic, anticholinergic drug
PDF page 420
Spasms of the gastrointestinal tract and genitourinary tract
PDF page 420
Do not administer to patients with benign prostatic hyperplasia, urinary retention, closed-angle glaucoma, tachycardia. May cause: urinary retention, dryness of the mouth, constipation, blurred vision, tachycardia (anticholinergic effects). Administer with caution and under close supervision: in the event of heart failure, coronary insufficiency, cardiac rhythm disorders, hypertension; to patients taking other anticholinergic drugs (antidepressants, antipsychotics, H-1 antihistamines, antiparkinsonians, etc.). Administer with caution to patients with fever (may affect thermoregulation). Pregnancy: no contra-indication; NO PROLONGED TREATMENT Breast-feeding: no contra-indication; NO PROLONGED TREATMENT
PDF pages 420, 421
20 mg in 1 ml ampoule (20 mg/ml) for IM, SC or slow IV injection
PDF page 420
Adult: 20 to 40 mg to be repeated if necessary (max. 100 mg daily)
PDF page 420
According to clinical response; no prolonged treatment.
PDF page 420
– Below 25 °C
PDF page 421
20 to 40 mg to be repeated if necessary (max. 100 mg daily)
PDF page 420